Ulcerative colitis (UC) is a type of inflammatory bowel ... Some healthcare providers prescribe a combination of oral and ...

Canada and at the European Crohn's and Colitis Organisation (ECCO) meeting held February 19-22 in Berlin. MB310 has been developed as an oral capsule, dosed once daily, containing a defined ...

The Company's Phase 2 trial for ulcerative colitis builds on previous research with oral PL8177. Earlier studies showed that the drug helps improve colon health by increasing the number of ...

for the treatment of moderate to severe active ulcerative colitis, met main goal. The trial showed positive clinical responses across all tested doses of icotrokinra, the company's targeted oral ...

Bioengineered Probiotic Yeast Medicines are oral, live therapeutics that express and secrete disease-targeting therapeutic molecules in situ for the treatment of gastrointestinal-related diseases.

with active ulcerative colitis, (defined as having a Mayo Endoscopic Total Score of at least two), for eight weeks of treatment. Treatment with oral PL8177 was well tolerated and no treatment ...